AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States.
$36.19-23.68%
报价 2026-11-06
市值
$1.4B
EV
$2.23B
PE (TTM)
17.4x
预期 PE (FY2026)
11.0x
52 周区间距高点 -26.1%
$15.10$49.00
筛选结果
pipeline · 2026-11-06Keep✗ 高增长✓ Cheap✓ GARP
Cheap Pool: EV/EBITDA <= 8, P/FCF <= 12
GARP Pool: growth 10-30%, PE <= 20, EV/EBITDA <= 12, P/FCF <= 20, MC/GP <= 11
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 0.8x | 4.25 → 0.94（0.2x） | 38.5 |
| FY+32028-12 | 0.8x | 4.25 → 1.26（0.3x） | 28.7 |
毛利率 28% · TTM 收入 $3517M · 基数 EPS 4.25（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| AMNAMN Healthcare Services, Inc. | $1.4B | -23.7% | +24.0% | 30.6% | 17.4x | 6.4x | 4.1x | Cheap GARP |
| MRVIMaravai LifeSciences Holdings, Inc. | $2.13B | +7.7% | +14.0% | 34.6% | – | – | – | |
| REPLReplimune Group, Inc. | $2.05B | +8.0% | +529.4% | 0% | – | – | – | |
| BFLYButterfly Network, Inc. | $1.7B | +4.9% | +36.1% | 73% | – | – | – | 高增长 |
| NUTXNutex Health, Inc. | $1.24B | -6.8% | -11.4% | 46.7% | 7.6x | 4.1x | 4.9x | |
| CMPSCOMPASS Pathways plc | $1.22B | +10.2% | – | 0% | – | – | – | |
| HSTMHealthStream, Inc. | $883.9M | -2.4% | +8.7% | 64.7% | 34.1x | 9.3x | 14.8x | |
| DNAGinkgo Bioworks Holdings, Inc. | $760.3M | +13.4% | -29.2% | 84.6% | – | – | – | |
| MYGNMyriad Genetics, Inc. | $566.2M | -5.9% | +5.1% | 68.8% | – | – | – | |
| 同行中位数 | – | – | +8.7% | 55.7% | 20.9x | 6.7x | 9.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $673.2M | $1.38B | $748.2M | $634.5M | $658.2M | $689.5M | $734.7M | $687.5M |
| Gross Margin | 30.6% | 26.8% | 26.1% | 29.1% | 29.8% | 28.7% | 29.8% | 31% |
| Operating Margin | 4% | 8.5% | 1.1% | 1.3% | -18.8% | 1.8% | -27.6% | 3.2% |
| Net Income | $21.2M | $62.2M | $-7.7M | $29.3M | $-116.2M | $-1.1M | $-187.5M | $7M |
| Diluted EPS | 0.53 | 1.59 | -0.2 | 0.76 | -3.02 | -0.03 | -4.9 | 0.18 |
| Operating Cash Flow | $-189.9M | $562.5M | $75.6M | $22.7M | $78.5M | $92.7M | $72.8M | $66.7M |